Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population

2 Mar 2023

Abstract excerpt

BACKGROUND: The frequency of HER2 overexpression in bladder cancer is reported as 9%-61%. HER2 alteration correlates with aggressive disease in bladder cancer. Traditional anti-HER2 targeted therapy has failed to show clinical benefits in patients with advanced urothelial carcinoma . METHODS: The information on pathologically proven patients with urothelial carcinoma with detected HER2 status was collected from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to HER2/EGFR in Cancer Research
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36971495
DOI: 10.1093/oncolo/oyad070

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese PopulationPMID 36971495Read ↗

HER2 protein overexpression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients.Semantic proximity Read ↗

Correlation of BRCA2 gene mutation and prognosis as well as variant genes in invasive urothelial carcinoma of the bladder.Semantic proximity Read ↗

The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 ExpressionSemantic proximity Read ↗

Morphological and molecular characteristics of HER2 amplified urothelial bladder cancerSemantic proximity Read ↗

The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectives.Semantic proximity Read ↗

High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancerSemantic proximity Read ↗

HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contextsSemantic proximity Read ↗

Durable Response to Trastuzumab Deruxtecan in a Patient with Urothelial Cancer and ERBB2 Mutation: A Case ReportSemantic proximity Read ↗

HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary BladderSemantic proximity Read ↗

Human epidermal growth factor receptor 2 ( HER2 ) gene amplification in non-muscle invasive urothelial bladder cancers: Identification of patients for targeted therapySemantic proximity Read ↗

c-erbb-2 gene amplification as a prognostic marker in human bladder cancerSemantic proximity Read ↗

Significant Association of Cyclo-oxygenase 2 Genotypes with Upper Tract Urothelial Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.